Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Jan 08, 2022 11:12am
148 Views
Post# 34296065

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Something big is likely in the works

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Something big is likely in the worksI was assuming that the carreer section on the website was accurate,,,but even if it is not the last version I think we know that there are still many unfilled positions,,,To be clear I am not predicting a take over ,,,,,What do you think id the company s goal in convening a meeting with major shareholders?


scarlet1967 wrote:

It's hard to know which positions have been filled, there is a discrepancy between their career section on the website and postings on LinkedIn. I am not sure the website gets updated as often as LinkedIn. Just in December they recruited two scientists also it seems like they are not just hiring but also laying off people as some employees on their LinkedIn account are not listed there now. At one point there were 114 people there and now down to 109. Point is why all the recent reshuffling if they are planning to sell the company? 


 

palinc2000 wrote:

 

Most of The positions advertised dont seem to have been filled so that would not be a problem but I dont think that a buyout is very likely at this stage...I am still wondering why a Meeting has been called with apparently no known agenda and no list of all participants.It cant be about running the business or discussing material info not yet disclosed to the public.... That leaves the other iption which is raising capital by way of a Private Placement .... hard to comment on that without knowing the terms ..
 

 

Bucknelly21 wrote: Do you really think they would do all that hiring to just settle for a buyout?

 

 





<< Previous
Bullboard Posts
Next >>